Literature DB >> 11068804

HIV prevention. Assisted reproduction in HIV-discordant couples.

C Gilling-Smith1.   

Abstract

Serodiscordant couples in whom the man is HIV-1-positive and the woman is negative have limited options if they wish to have children safely, because sexual intercourse carries a 1-in-500 risk of transmitting virus in semen to the female partner. Sperm washing is a risk-reduction option in which infected sperm are washed free of virus before insemination into the female partner at the time of ovulation. Absence of detectable HIV is verified before insemination using a polymerase chain reaction nucleic acid-based sequence amplification assay. Pregnancy rate per insemination is 14%, based on a European experience of more than 2000 inseminations; to date, there have been no seroconversions in either mother or child. Washed sperm have also been used in other assisted conception treatments, such as in vitro fertilization. In the United States, the CDC has recommended against insemination of women with semen from men infected with HIV. Current data from programs in Europe would suggest sperm washing to be a safe risk-reduction option for heterosexual couples wishing to bear a child. We suggest that sperm washing should only be carried out in dedicated units using a multidisciplinary approach to ensure that couples receive adequate preconceptual counseling, detailed sexual health and fertility assessment, and careful monitoring of the woman's HIV status during treatment and pregnancy.

Entities:  

Mesh:

Year:  2000        PMID: 11068804

Source DB:  PubMed          Journal:  AIDS Read        ISSN: 1053-0894


  9 in total

1.  HIV and infertility: time to treat. There's no justification for denying treatment to parents who are HIV positive.

Authors:  C Gilling-Smith; J R Smith; A E Semprini
Journal:  BMJ       Date:  2001-03-10

Review 2.  Use of assisted reproductive technology to reduce the risk of transmission of HIV in discordant couples wishing to have their own children where the male partner is seropositive with an undetectable viral load.

Authors:  H W G Baker; A Mijch; S Garland; S Crowe; M Dunne; D Edgar; G Clarke; P Foster; J Blood
Journal:  J Med Ethics       Date:  2003-12       Impact factor: 2.903

3.  Implementation of a safer conception service for HIV-affected couples in South Africa.

Authors:  Sheree R Schwartz; Jean Bassett; Ian Sanne; Rebecca Phofa; Nompumelelo Yende; Annelies Van Rie
Journal:  AIDS       Date:  2014-07       Impact factor: 4.177

4.  The right to choose parenthood among HIV-infected women and men.

Authors:  Joanne E Mantell; Jennifer A Smit; Zena A Stein
Journal:  J Public Health Policy       Date:  2009-12       Impact factor: 2.222

5.  Acceptability and preferences for safer conception HIV prevention strategies: a qualitative study.

Authors:  Sheree R Schwartz; Nora West; Rebecca Phofa; Nompumelelo Yende; Ian Sanne; Jean Bassett; Annelies Van Rie
Journal:  Int J STD AIDS       Date:  2015-09-18       Impact factor: 1.359

6.  Access to infertility services in Canada for HIV-positive individuals and couples: a cross-sectional study.

Authors:  Mark H Yudin; Heather M Shapiro; Mona R Loutfy
Journal:  Reprod Health       Date:  2010-05-12       Impact factor: 3.223

7.  Yes, It is Possible.

Authors:  Gautam N Allahbadia
Journal:  J Obstet Gynaecol India       Date:  2015-11-13

Review 8.  Strategies for Preventing HIV Infection Among HIV-Uninfected Women Attempting Conception with HIV-Infected Men - United States.

Authors:  Jennifer F Kawwass; Dawn K Smith; Dmitry M Kissin; Lisa B Haddad; Sheree L Boulet; Saswati Sunderam; Denise J Jamieson
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-06-02       Impact factor: 17.586

9.  Assisted reproductive technology and obstetric outcome in couples when the male partner has a chronic viral disease.

Authors:  Irene Molina; María Carmen Del Gonzalvo; Ana Clavero; Miguel Angel López-Ruz; Juan Mozas; Juan Pasquau; Antonio Sampedro; Luis Martínez; José Antonio Castilla
Journal:  Int J Fertil Steril       Date:  2013-12-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.